CHAMBERLAIN UNIVERSITY — GRADUATE CLINICAL TRACK
MID-TERM PHARMACOLOGY
QUESTIONS
2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS
AGRADE STUDY COMPANION & REVISION MANUAL
Subject: Advanced Practice Clinical Pharmacology
Course Code: NURS 602 / Advanced Pharmacology Series
Audience: Family Nurse Practitioner (FNP) Candidates
Document Type: Comprehensive Revision Test Bank & Study Guide
Total Items: 105 High-Yield Scenario-Based Questions with Rationales
Update Cycle: 2026-2027 Academic Year
,MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
TABLE OF CONTENTS & EXAM BLUEPRINT
This verified study resource is programmatically mapped to the core advanced pharmacology curriculum.
Below is the organizational layout and blueprint of the 105 practice items:
• SECTION I: Cardiovascular & Hematology Pharmacotherapy ...................................................... Pages
3 – 14
Focus: Anticoagulants, loop/thiazide diuretics, statins, and antianginal hemodynamics.
• SECTION II: Anti-Infective & Immunological Pharmacotherapy .................................................. Pages
15 – 24
Focus: Beta-lactams, macrolides, aminoglycosides, clindamycin, and systemic antifungals.
• SECTION III: Neurology, Psychiatry & Behavioral Health ........................................................... Pages
25 – 31
Focus: Opioids, scheduled drugs, adjuvant analgesics, and benzodiazepine safety.
• SECTION IV: General Principles of Clinical Pharmacology ..............................................................
Pages 32 – 37
Focus: Pharmacokinetics (ADME), Beers Criteria, pediatric dosing, and prescriptive authority laws.
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 2 of 37
,MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
SECTION I: CARDIOVASCULAR & HEMATOLOGY PHARMACOTHERAPY
Question 1 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following represents the most common cause of iron deficiency in patients, especially in adult populations?
A. Rapid growth during adolescence. B. Vegetarian eating patterns.
C. Decreased intestinal uptake of iron. D. Chronic blood loss through the gastrointestinal tract.
ANSWER ■: D
Explanation: Chronic blood loss through the gastrointestinal tract (such as from ulcers, malignancies, or chronic NSAID use) is the most common cause of iron deficiency
anemia in adults. While rapid growth during adolescence (A) and vegetarian diets (B) can contribute to iron deficiency, GI blood loss remains the primary cause in clinical
practice.
Question 2 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following represents the most common type of anemia diagnosed globally?
A. Iron deficiency anemia. B. Aplastic anemia.
C. Hemolytic anemia. D. Pernicious anemia.
ANSWER ■: A
Explanation: Iron deficiency anemia is the most common type of anemia worldwide. It is caused by inadequate iron supply for hemoglobin synthesis, resulting from
chronic blood loss, poor dietary intake, or impaired absorption.
Question 3 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: An older adult patient is receiving digoxin and warfarin therapy. A macrolide antibiotic is required to treat a streptococcal infection. In a patient with a severe
penicillin sensitivity (anaphylaxis), which macrolide is the safest option to avoid drug-drug interactions?
A. Clarithromycin. B. Telithromycin.
C. Azithromycin. D. Erythromycin.
ANSWER ■: C
Explanation: Azithromycin does not inhibit the CYP3A4 enzyme or P-glycoprotein, making it the safest macrolide for patients taking digoxin and warfarin. Clarithromycin
(A) and erythromycin (D) are potent inhibitors of CYP3A4 and P-gp, which can precipitously elevate serum digoxin and warfarin concentrations, leading to toxicities
(arrhythmias and bleeding).
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 3 of 37
, MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
SECTION I: CARDIOVASCULAR & HEMATOLOGY PHARMACOTHERAPY
Question 4 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following physiological changes in the elderly accounts for a smaller volume of distribution and a concomitant increase in plasma concentrations of
digoxin?
A. Decreased total body water. B. Increased total body water.
C. Increased activity of hepatic enzymes. D. Decreased rate of elimination due to decreased renal function.
ANSWER ■: A
Explanation: Digoxin is a hydrophilic drug that distributes widely into skeletal muscle and body water. Elderly patients have a physiological decrease in total body water
and muscle mass, resulting in a smaller volume of distribution (Vd) and higher plasma concentrations of digoxin, placing them at increased risk for toxicity.
Question 5 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: A patient with congestive heart failure requires a diuretic. The patient has a history of chronic kidney disease (CKD) with a glomerular filtration rate (GFR) of less
than 30 mL/min. Which diuretic class/agent should the NP prescribe?
A. Metolazone. B. Methyclothiazide.
C. Furosemide. D. Hydrochlorothiazide.
ANSWER ■: C
Explanation: Furosemide (a loop diuretic) remains effective even when the GFR falls below 30 mL/min, making it the preferred choice for fluid overload in
moderate-to-severe CKD. Thiazide diuretics, such as hydrochlorothiazide (D) and methyclothiazide (B), are generally ineffective when the GFR is less than 30 mL/min.
Question 6 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following laboratory tests must be obtained at baseline prior to initiating statin therapy (HMG-CoA reductase inhibitor)?
A. Platelet count. B. Urinalysis.
C. Liver function tests (LFTs). D. Thyroid-stimulating hormone (TSH).
ANSWER ■: C
Explanation: Baseline liver function tests (AST/ALT) are required before starting statin therapy to screen for underlying hepatic dysfunction, as statins can cause a
dose-dependent increase in serum transaminases.
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 4 of 37
MID-TERM PHARMACOLOGY
QUESTIONS
2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS
AGRADE STUDY COMPANION & REVISION MANUAL
Subject: Advanced Practice Clinical Pharmacology
Course Code: NURS 602 / Advanced Pharmacology Series
Audience: Family Nurse Practitioner (FNP) Candidates
Document Type: Comprehensive Revision Test Bank & Study Guide
Total Items: 105 High-Yield Scenario-Based Questions with Rationales
Update Cycle: 2026-2027 Academic Year
,MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
TABLE OF CONTENTS & EXAM BLUEPRINT
This verified study resource is programmatically mapped to the core advanced pharmacology curriculum.
Below is the organizational layout and blueprint of the 105 practice items:
• SECTION I: Cardiovascular & Hematology Pharmacotherapy ...................................................... Pages
3 – 14
Focus: Anticoagulants, loop/thiazide diuretics, statins, and antianginal hemodynamics.
• SECTION II: Anti-Infective & Immunological Pharmacotherapy .................................................. Pages
15 – 24
Focus: Beta-lactams, macrolides, aminoglycosides, clindamycin, and systemic antifungals.
• SECTION III: Neurology, Psychiatry & Behavioral Health ........................................................... Pages
25 – 31
Focus: Opioids, scheduled drugs, adjuvant analgesics, and benzodiazepine safety.
• SECTION IV: General Principles of Clinical Pharmacology ..............................................................
Pages 32 – 37
Focus: Pharmacokinetics (ADME), Beers Criteria, pediatric dosing, and prescriptive authority laws.
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 2 of 37
,MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
SECTION I: CARDIOVASCULAR & HEMATOLOGY PHARMACOTHERAPY
Question 1 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following represents the most common cause of iron deficiency in patients, especially in adult populations?
A. Rapid growth during adolescence. B. Vegetarian eating patterns.
C. Decreased intestinal uptake of iron. D. Chronic blood loss through the gastrointestinal tract.
ANSWER ■: D
Explanation: Chronic blood loss through the gastrointestinal tract (such as from ulcers, malignancies, or chronic NSAID use) is the most common cause of iron deficiency
anemia in adults. While rapid growth during adolescence (A) and vegetarian diets (B) can contribute to iron deficiency, GI blood loss remains the primary cause in clinical
practice.
Question 2 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following represents the most common type of anemia diagnosed globally?
A. Iron deficiency anemia. B. Aplastic anemia.
C. Hemolytic anemia. D. Pernicious anemia.
ANSWER ■: A
Explanation: Iron deficiency anemia is the most common type of anemia worldwide. It is caused by inadequate iron supply for hemoglobin synthesis, resulting from
chronic blood loss, poor dietary intake, or impaired absorption.
Question 3 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: An older adult patient is receiving digoxin and warfarin therapy. A macrolide antibiotic is required to treat a streptococcal infection. In a patient with a severe
penicillin sensitivity (anaphylaxis), which macrolide is the safest option to avoid drug-drug interactions?
A. Clarithromycin. B. Telithromycin.
C. Azithromycin. D. Erythromycin.
ANSWER ■: C
Explanation: Azithromycin does not inhibit the CYP3A4 enzyme or P-glycoprotein, making it the safest macrolide for patients taking digoxin and warfarin. Clarithromycin
(A) and erythromycin (D) are potent inhibitors of CYP3A4 and P-gp, which can precipitously elevate serum digoxin and warfarin concentrations, leading to toxicities
(arrhythmias and bleeding).
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 3 of 37
, MID-TERM PHARMACOLOGY QUESTIONS — EXAM STUDY GUIDE 2026-2027 UPDATE EXAM — 100% VERIFIED QUESTIONS & ANSWERS (A+ GRADE)
SECTION I: CARDIOVASCULAR & HEMATOLOGY PHARMACOTHERAPY
Question 4 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following physiological changes in the elderly accounts for a smaller volume of distribution and a concomitant increase in plasma concentrations of
digoxin?
A. Decreased total body water. B. Increased total body water.
C. Increased activity of hepatic enzymes. D. Decreased rate of elimination due to decreased renal function.
ANSWER ■: A
Explanation: Digoxin is a hydrophilic drug that distributes widely into skeletal muscle and body water. Elderly patients have a physiological decrease in total body water
and muscle mass, resulting in a smaller volume of distribution (Vd) and higher plasma concentrations of digoxin, placing them at increased risk for toxicity.
Question 5 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: A patient with congestive heart failure requires a diuretic. The patient has a history of chronic kidney disease (CKD) with a glomerular filtration rate (GFR) of less
than 30 mL/min. Which diuretic class/agent should the NP prescribe?
A. Metolazone. B. Methyclothiazide.
C. Furosemide. D. Hydrochlorothiazide.
ANSWER ■: C
Explanation: Furosemide (a loop diuretic) remains effective even when the GFR falls below 30 mL/min, making it the preferred choice for fluid overload in
moderate-to-severe CKD. Thiazide diuretics, such as hydrochlorothiazide (D) and methyclothiazide (B), are generally ineffective when the GFR is less than 30 mL/min.
Question 6 of 105
Learning Objective: Apply advanced clinical reasoning and pharmaceutical safety parameters to patient care.
Question: Which of the following laboratory tests must be obtained at baseline prior to initiating statin therapy (HMG-CoA reductase inhibitor)?
A. Platelet count. B. Urinalysis.
C. Liver function tests (LFTs). D. Thyroid-stimulating hormone (TSH).
ANSWER ■: C
Explanation: Baseline liver function tests (AST/ALT) are required before starting statin therapy to screen for underlying hepatic dysfunction, as statins can cause a
dose-dependent increase in serum transaminases.
CHAMBERLAIN UNIVERSITY — ADVANCED PRACTICE CLINICAL PHARMACOLOGY Page 4 of 37
